Researchers create an AI model integrating genetic, clinical, and transcriptomic data to identify individuals at risk for thrombosis.
Key Details
- 1A new AI tool analyzes over 12,900 genes alongside clinical and genetic data to model thrombosis risk.
- 2Study involved 790 individuals from families with a history of venous thrombosis, including 70 with idiopathic thrombosis.
- 3494 genes, including many noncoding RNAs, were identified as associated with thrombosis risk.
- 4Adding transcriptomic data improved patient classification: those classified 'high-risk' without thrombosis dropped from 43% to 23%.
- 5The research was published in the Journal of Thrombosis and Haemostasis and still requires external validation.
Why It Matters
The study highlights how integrating genomic and transcriptomic profiles via AI can provide more precise risk stratification than clinical factors alone, pointing toward more personalized and data-driven approaches in disease prevention—relevant as similar data integration strategies emerge in radiology and imaging AI.
Source
EurekAlert
Related News
•EurekAlert
USC Receives $3M Gift for Alzheimer's Research Involving Imaging and AI
A $3 million donation to USC will accelerate Alzheimer's research, including imaging modality development and AI-based molecular analysis.
•EurekAlert
AI Pathology Analysis Predicts Immunotherapy Response in Rare Tumors
AI-based analysis of tumor pathology slides can predict immunotherapy outcomes in rare cancers, according to a recent MD Anderson study.
•EurekAlert
Review Highlights AI's Impact on Breast Cancer Imaging and Recurrence Prediction
A major review details how AI enhances early detection and recurrence prediction in breast cancer imaging.